论文部分内容阅读
自1980年以来,我院用乙胺碘呋酮治疗持续性房颤33例疗效满意,现报道如下。一、病例资料。对象为房颤持续时间超过6周,无乙胺碘呋酮禁忌症之患者。全组33例,男17例,女16例,年龄24~85岁,其中50岁以上者16例。病因:风心病16例,冠心病14例,原发性房颤2例,梅毒性心脏病1例。房颤时程:6周~64月,其中6周~1年者25例,4~5年者8例。心功能Ⅰ、Ⅱ级者17例,Ⅲ、Ⅳ级者16例。二、用药方法。均采用口服给药,其中27,例为0.6克/日,其余6例或取剂量递增或
Since 1980, our hospital with amiodarone treatment of persistent atrial fibrillation in 33 cases of satisfactory results are reported below. First, the case information. Subjects with atrial fibrillation duration of more than 6 weeks, no amiodarone contraindications in patients. The whole group of 33 cases, 17 males and 16 females, aged 24 to 85 years old, of which more than 50 years old in 16 cases. Etiology: rheumatic heart disease in 16 cases, coronary heart disease in 14 cases, 2 cases of primary atrial fibrillation, syphilitic heart disease in 1 case. Atrial fibrillation duration: 6 weeks to 64 months, of which 6 weeks to 1 year in 25 cases, 4 to 5 years in 8 cases. Heart function Ⅰ, Ⅱ grade in 17 cases, Ⅲ, Ⅳ grade in 16 cases. Second, medication methods. Are used orally, of which 27 cases were 0.6 g / day, and the remaining 6 cases or take the dose increasing or